The research is part of a growing understanding about how many factors influence brain health as we age – and what we can do ...

Abrysvo is now approved in the EU for adults aged 18 to 59 who are at increased risk of lower respiratory tract disease ...

The report said GSK’s former head of vaccine development, Philip Dormitzer, who joined the company after working at ...

Years after the biopharmaceutical industry stepped up to create COVID-19 vaccines as the virus spiraled into a global ...

Trump has claimed the company delayed an announcement for its vaccine until after the 2020 presidential election.

President Trump has claimed in the past Pfizer sat on positive vaccine data, but no evidence has supported the accusation.

GSK said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its ...

Pfizer PFE announced that the European Commission (“EC”) has granted marketing authorization to expand the use of its RSV ...

The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...

French drugmaker Sanofi (Euronext: SAN) has appointed Chris Corsico as its new global head of development, according to an ...

Shares in Moderna, Vaxcyte, Novavax and BioNTech all fell Monday after Peter Marks, head of the FDA office that reviews ...

Vaxcyte, Inc.'s stock fell 50% despite positive vaccine results. See how FDA uncertainty, competition, and Phase 3 delays ...